109229
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
癌症患者对中医技术接受度量表：开发与验证
Authors Yang L , Sheng X, Lin J, Wang W, Wu X, Lin R , Liu A, Liu L
Received 30 June 2025
Accepted for publication 23 October 2025
Published 7 November 2025 Volume 2025:19 Pages 3509—3525
DOI https://doi.org/10.2147/PPA.S550541
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Ramón Morillo-Verdugo
Liu Yang,1,* Xia Sheng,2,* Jiayi Lin,1 Weina Wang,1 Xinlei Wu,1 Rujia Lin,1 Aiqin Liu,3 Limin Liu4
1School of Nursing, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People’s Republic of China; 2Nursing Department, Fujian Provincial 2nd People’s Hospital, Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China; 3Department of Integrated Traditional Chinese and Western Medicine, Clinical Oncology School of Fujian Medical University (Fujian Cancer Hospital), Fuzhou, People’s Republic of China; 4Hematology Department, The Third Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Liu Yang, School of Nursing, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Shangjie, Minhou, Fuzhou, Fujian, Tel +86 13959148480, Email yangliu@fjtcm.edu.cn
Background: Traditional Chinese Medicine techniques have unique advantages in complementary cancer treatment, and their clinical application largely relies on patient acceptance. Scientific assessment of patients’ acceptance of Traditional Chinese Medicine techniques is a key step in promoting their clinical application. However, no scientifically validated tools exist to assess cancer patients’ acceptance of Traditional Chinese Medicine techniques.
Purpose: To develop and validate the acceptance scale for Traditional Chinese Medicine techniques in cancer patients.
Patients and Methods: The study involved scale development and psychometric testing. Items were generated via conceptual definition, literature review, and qualitative research based on the Technology Acceptance Model. Two rounds of expert review and a pilot study refined the scale and assessed content validity. Psychometric evaluation was conducted on 370 cancer patients, including item analysis, exploratory and confirmatory factor analysis, validity assessments, and reliability testing.
Results: The finalized 25-item scale has four dimensions: perceived usefulness, perceived ease of use, behavioral intention, and apprehensions about usage. Content validity indices ranged from 0.933 to 1.000. Exploratory factor analysis revealed four common factors, accounting for 66.6% of the variance. Confirmatory factor analysis showed good fit (χ2/df=2.304, GFI=0.803, CFI=0.907, NFI=0.847, RMSEA=0.079). Convergent validity indicated Average Variance Extraction values of 0.493– 0.679 and Composite Reliability of 0.858– 0.913. Correlations between dimensions ranged from 0.624 to 0.730, with satisfactory discriminant validity. Reliability was high (Cronbach’s alpha=0.951, split-half=0.871, test-retest=0.876).
Conclusion: This scale is a reliable and effective tool for assessing cancer patients’ acceptance of Traditional Chinese Medicine techniques. It provides guidance for clinical practice and research involving these techniques.
Keywords: acceptance, neoplasms, scale development, traditional Chinese medicine, validity and reliability
1School of Nursing, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People’s Republic of China; 2Nursing Department, Fujian Provincial 2nd People’s Hospital, Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China; 3Department of Integrated Traditional Chinese and Western Medicine, Clinical Oncology School of Fujian Medical University (Fujian Cancer Hospital), Fuzhou, People’s Republic of China; 4Hematology Department, The Third Affiliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Liu Yang, School of Nursing, Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Shangjie, Minhou, Fuzhou, Fujian, Tel +86 13959148480, Email yangliu@fjtcm.edu.cn
Background: Traditional Chinese Medicine techniques have unique advantages in complementary cancer treatment, and their clinical application largely relies on patient acceptance. Scientific assessment of patients’ acceptance of Traditional Chinese Medicine techniques is a key step in promoting their clinical application. However, no scientifically validated tools exist to assess cancer patients’ acceptance of Traditional Chinese Medicine techniques.
Purpose: To develop and validate the acceptance scale for Traditional Chinese Medicine techniques in cancer patients.
Patients and Methods: The study involved scale development and psychometric testing. Items were generated via conceptual definition, literature review, and qualitative research based on the Technology Acceptance Model. Two rounds of expert review and a pilot study refined the scale and assessed content validity. Psychometric evaluation was conducted on 370 cancer patients, including item analysis, exploratory and confirmatory factor analysis, validity assessments, and reliability testing.
Results: The finalized 25-item scale has four dimensions: perceived usefulness, perceived ease of use, behavioral intention, and apprehensions about usage. Content validity indices ranged from 0.933 to 1.000. Exploratory factor analysis revealed four common factors, accounting for 66.6% of the variance. Confirmatory factor analysis showed good fit (χ2/df=2.304, GFI=0.803, CFI=0.907, NFI=0.847, RMSEA=0.079). Convergent validity indicated Average Variance Extraction values of 0.493– 0.679 and Composite Reliability of 0.858– 0.913. Correlations between dimensions ranged from 0.624 to 0.730, with satisfactory discriminant validity. Reliability was high (Cronbach’s alpha=0.951, split-half=0.871, test-retest=0.876).
Conclusion: This scale is a reliable and effective tool for assessing cancer patients’ acceptance of Traditional Chinese Medicine techniques. It provides guidance for clinical practice and research involving these techniques.
Keywords: acceptance, neoplasms, scale development, traditional Chinese medicine, validity and reliability